Xavier Rodrigue

Co-Applicant
Associate Clinical Professor, Rehabilitation, Université Laval
Chief Physiatrist, CIUSSSCN
NMD4C Involvement: Pillar 2: Clinical Research, Pillar 3: Clinical Practice Research
Email XavierResearch Interests: Neuromuscular diseases, Amputation, Gait defects, Neuropathic and phantom pain
Academic web profileResearchGate profile
Biography
Dr. Xavier Rodrigue is an Associate Clinical Professor of Rehabilitation at Université Laval, and Chief Physiatrist at CIUSSSCN. He specializes in the rehabilitation of children and adults with neuromuscular diseases, patients that have undergone amputation, gait defects, orthotics-prostheses, and neuropathic and phantom pain. He will participate in Clinical Trial Network, and Community of Practice.
Recent Publications
Lessard, I, Hébert, LJ, Brais, B, Duchesne, E, Rodrigue, X, Brisson, JD et al.. Selection of Clinical Outcome Assessments for Trial Readiness in ARSACS - 2-year Progression and Responsiveness to Change Part 1: Disease Severity, Swallowing, Upper Limb Function, and Participation. Cerebellum. 2025.24 (4)106 PMID:40450178
O'Connell, C, Rodrigue, X, Hodgkinson, V, Henley, K, Slayter, J, Aleman, A et al.. Thinking outside the box: A re-evaluation of Canadian recommended outcome measures in adult spinal muscular atrophy - report of a national consensus workshop. J Neuromuscul Dis. 2025. 22143602251336076 PMID:40356341
Lessard, I, Duchesne, E, Hébert, LJ, Brais, B, Rodrigue, X, Routhier, F et al.. Selection of Clinical Outcome Assessments for Trial Readiness in ARSACS - 2-year Progression and Responsiveness to Change Part 2: Mobility, Balance, and Lower Limb Coordination. Cerebellum. 2025.24 (4)95 PMID:40332679
Côté, I, Hodgkinson, V, Nury, M, Bastenier-Boutin, L, Rodrigue, X. A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3. Can J Neurol Sci. 2025.52 (1)119-128 PMID:38532567
Lessard, I, Côté, I, St-Gelais, R, Hébert, LJ, Brais, B, Mathieu, J et al.. Natural History of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay: a 4-Year Longitudinal Study. Cerebellum. 2024.23 (2)489-501 PMID:37101017
Shaikh, AG, Kim, JS, Froment, C, Koo, YJ, Dupre, N, Hadjivassiliou, M et al.. Scale for Ocular motor Disorders in Ataxia (SODA). J Neurol Sci. 2022.443 120472 PMID:36403298
Slayter, J, Hodgkinson, V, Lounsberry, J, Brais, B, Chapman, K, Genge, A et al.. A Canadian Adult Spinal Muscular Atrophy Outcome Measures Toolkit: Results of a National Consensus using a Modified Delphi Method. J Neuromuscul Dis. 2021.8 (4)579-588 PMID:33867362
Bourassa, J, Routhier, F, Gagnon, C, Rahn, C, Hébert, LJ, St-Gelais, R et al.. Wheelchair mobility, motor performance and participation of adult wheelchair users with ARSACS: a cross-sectional study. Disabil Rehabil Assist Technol. 2023.18 (4)378-386 PMID:33307884
Bourcier, D, Bélanger, M, Côté, I, Brais, B, Synofzik, M, Brisson, JD et al.. Documenting the psychometric properties of the scale for the assessment and rating of ataxia to advance trial readiness of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay. J Neurol Sci. 2020.417 117050 PMID:32736199
Hodgkinson, VL, Chapman, K, Izenberg, A, Lochmüller, H, O'Connell, C, O'Ferrall, EK et al.. Response to Provincial Governments' Decisions Regarding Monitoring for Adults with Spinal Muscular Atrophy. Can J Neurol Sci. 2021.48 (2)201-203 PMID:32713403
See more on PubMed